CANTOR FITZGERALD, L. P.
Position in CERO — Cero Therapeutics Holdings, Inc.
CIK 1024896
NEW YORK, NY
Position in CERO
as of Jun 30, 2025
· filed Aug 14, 2025
Position Value
$0
+$0 QoQ
Shares Held
441,048
0.0% QoQ
Ownership
0.616%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CERO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANTOR FITZGERALD, L. P. holds $32,286,928 across 25 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMCR |
Immunocore Holdings plc
|
340,100 | $10,798,175 | |
| 2 | RNA |
Atrium Therapeutics, Inc.
|
256,917 | $3,455,533 | |
| 3 | INSM |
INSMED Inc
|
25,000 | $2,665,500 | |
| 4 | CABA |
Cabaletta Bio, Inc.
|
800,001 | $2,488,003 | |
| 5 | MRNA |
Moderna, Inc.
|
22,772 | $1,594,723 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
35,000 | $1,354,500 | |
| 7 | PTHS |
Pelthos Therapeutics Inc.
|
38,123 | $1,077,355 | |
| 8 | ACHV |
Achieve Life Sciences, Inc.
|
121,631 | $794,250 |
All Filings in CERO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2024-12-31 | $9,300 | 155,000 | Shares | Defined | 2025-02-14 | |
| 2023-12-31 | $2 | 155,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2 | 155,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2 | 155,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | — | 155,000 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $7,515,000 | 750,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,488,750 | 750,000 | Shares | Defined | 2022-05-23 | |
| 2021-12-31 | $7,432,500 | 750,000 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||